首页> 美国卫生研究院文献>Molecular Medicine Reports >Construction and characterization of a transmembrane eukaryotic expression vector based on the membrane domain structure of TNF-α
【2h】

Construction and characterization of a transmembrane eukaryotic expression vector based on the membrane domain structure of TNF-α

机译:基于TNF-α膜结构的跨膜真核表达载体的构建与表征

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

The aim of the present study was to construct a fast-acting, eukaryotic expression vector in eukaryotic cells based on transmembrane-tumor necrosis factor-α (TM-TNF-α) structure. Two types of recombinant eukaryotic expression vectors were constructed, pcDNA3.1-TM-enterokinase-TNF-α and pcDNA3.1-TM-Factor Xa-TNF-α, according to the TNF-α transmembrane segments. Following the generation of these vectors, mouse embryonic 3T3 fibroblasts were transfected and reverse transcription-polymerase chain reaction and western blotting analyses were used to analyze mTNF-α mRNA and protein expression levels, respectively, in total cellular protein extracts and extracellular fluid. The biological activity of TNF-α in the extracellular fluid was then measured using an MTT assay. The vectors were successfully constructed, and mRNA and fusion proteins were detected in the 3T3 cells. Among the fusion proteins, the one observed in pcDNA3.1-TM-FactorXa-TNF-α-transfected 3T3 cells remained as a transmembrane protein. In addition, treatment of L929 cells with TNF-α derived extracellular fluid samples from pcDNA3.1-TM-FactorXa-TNF-α-transfected 3T3 cells was associated with a dose-dependent reduction in in cell-specific activity. The results indicate that proteins expressed using pcDNA3.1-TM-FactorXa-TNF-α vectors form transmembrane proteins. In addition, the results indicate that, only when coupled with FactorXa activity, the extracellular region of TM-TNF-α forms s-TNF-α, and the controlled expression of the fusion protein is initiated.
机译:本研究的目的是在跨膜肿瘤坏死因子-α(TM-TNF-α)结构的基础上,在真核细胞中构建快速反应的真核表达载体。根据TNF-α跨膜区段,构建了两种类型的重组真核表达载体,pcDNA3.1-TM-肠激酶-TNF-α和pcDNA3.1-TM-因子Xa-TNF-α。产生这些载体后,转染小鼠胚胎3T3成纤维细胞,并使用反转录-聚合酶链反应和蛋白质印迹分析分别分析了总细胞蛋白提取物和细胞外液中的mTNF-αmRNA和蛋白表达水平。然后使用MTT测定法测量细胞外液中TNF-α的生物活性。成功构建了载体,并在3T3细胞中检测到mRNA和融合蛋白。在融合蛋白中,在pcDNA3.1-TM-FactorXa-TNF-α转染的3T3细胞中观察到的一种保持为跨膜蛋白。另外,用来自pcDNA3.1-TM-FactorXa-TNF-α转染的3T3细胞的TNF-α衍生的细胞外液样品处理L929细胞与剂量依赖性细胞特异性活性降低有关。结果表明,使用pcDNA3.1-TM-FactorXa-TNF-α载体表达的蛋白质形成跨膜蛋白质。此外,结果表明,仅当与FactorXa活性偶联时,TM-TNF-α的细胞外区域形成s-TNF-α,并且融合蛋白的受控表达开始。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号